AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2022
Jun 10, 2022
32559_dirs_2022-06-10_f95d4603-d75d-412c-9872-beccd27b674b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2022-05-31
Reporting Person: Russell Kerry Strong (N/A)